NUPHARMING Trademark

Trademark Overview

On Tuesday, October 20, 2020, a trademark application was filed for NUPHARMING with the United States Patent and Trademark Office. The USPTO has given the NUPHARMING trademark a serial number of 90266195. The federal status of this trademark filing is REGISTERED as of Tuesday, April 12, 2022. This trademark is owned by Nevakar Inc.. The NUPHARMING trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical products development
nupharming

General Information

Serial Number90266195
Word MarkNUPHARMING
Filing DateTuesday, October 20, 2020
Status700 - REGISTERED
Status DateTuesday, April 12, 2022
Registration Number6702564
Registration DateTuesday, April 12, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 27, 2021

Trademark Statements

Goods and ServicesPharmaceutical products development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 8, 2020
Primary Code042
First Use Anywhere DateMonday, October 19, 2020
First Use In Commerce DateMonday, October 19, 2020

Trademark Owner History

Party NameNevakar Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807
Party NameNevakar Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807
Party NameNevakar Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBridgewater, NJ 08807

Trademark Events

Event DateEvent Description
Wednesday, May 10, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, April 12, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, March 10, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, March 9, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 8, 2022STATEMENT OF USE PROCESSING COMPLETE
Thursday, January 27, 2022USE AMENDMENT FILED
Tuesday, March 8, 2022SOU EXTENSION 1 GRANTED
Wednesday, December 22, 2021SOU EXTENSION 1 FILED
Monday, March 7, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 28, 2022NOTICE OF REVIVAL - E-MAILED
Thursday, January 27, 2022EXTENSION RECEIVED WITH TEAS PETITION
Thursday, January 27, 2022PETITION TO REVIVE-GRANTED
Thursday, January 27, 2022TEAS PETITION TO REVIVE RECEIVED
Thursday, January 27, 2022TEAS STATEMENT OF USE RECEIVED
Monday, January 24, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 24, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 22, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 27, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, March 21, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 20, 2021ASSIGNED TO EXAMINER
Tuesday, December 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 23, 2020NEW APPLICATION ENTERED

Related Keywords

nupharming development products pharmaceutical